GC
GBT
Grace Capital’s Global Blood Therapeutics, Inc. GBT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $3.83M | Buy |
130,949
+2,300
| +2% | +$67.3K | 2.28% | 11 |
|
|
2021
Q3 | $3.97M | Buy |
128,649
+2,400
| +2% | +$74.1K | 2.44% | 8 |
|
|
2021
Q2 | $4.42M | Sell |
126,249
-3,900
| -3% | -$137K | 2.96% | 7 |
|
|
2021
Q1 | $5.3M | Sell |
130,149
-1,400
| -1% | -$57.1K | 3.37% | 4 |
|
|
2020
Q4 | $5.7M | Buy |
131,549
+6,800
| +5% | +$294K | 3.6% | 3 |
|
|
2020
Q3 | $6.88M | Sell |
124,749
-13,900
| -10% | -$766K | 5.33% | 2 |
|
|
2020
Q2 | $8.75M | Sell |
138,649
-7,780
| -5% | -$491K | 7.52% | 1 |
|
|
2020
Q1 | $7.48M | Sell |
146,429
-30,985
| -17% | -$1.58M | 7.35% | 1 |
|
|
2019
Q4 | $14.1M | Sell |
177,414
-64,600
| -27% | -$5.14M | 11.5% | 1 |
|
|
2019
Q3 | $11.7M | Sell |
242,014
-2,900
| -1% | -$141K | 11.86% | 1 |
|
|
2019
Q2 | $12.9M | Sell |
244,914
-19,100
| -7% | -$1M | 6.14% | 1 |
|
|
2019
Q1 | $14M | Buy |
264,014
+163,885
| +164% | +$8.67M | 5.45% | 1 |
|
|
2018
Q4 | $4.11M | Sell |
100,129
-212,385
| -68% | -$8.72M | 1.91% | 8 |
|
|
2018
Q3 | $11.9M | Buy |
312,514
+213,575
| +216% | +$8.12M | 4.65% | 1 |
|
|
2018
Q2 | $14M | Buy |
+98,939
| New | +$14M | 5.34% | 1 |
|